William Kim, MD (IMAGE) UNC Lineberger Comprehensive Cancer Center Caption William Kim, MD, and colleagues report that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in mice. This approach shows such promise that it’s already being tested in an ongoing clinical trial in people with advanced bladder cancer. Credit UNC Lineberger Usage Restrictions None License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.